[1] Sutherland M. C., Osborne C. K.: "Tamoxifen in premenopausal patients with metastatic breast cancer: a review". J. Clin. Oneal., 1991, 9, 1283.
[2] Goldhirsch A., Gelber R. D., Castiglione M.: "International Breast Cancer Study Group. Adjuvant therapy of breast cancer". Eur. J. Cancer, 1991, 27, 399.
[3] Ziegler L. D., Buzdar A. U.: " Current status of adjuvant therapy of early breast cancer". Am. J. Clin. Oneal., 1991, 14, 101.
[4] Buchanan R. B., Blarney R. W., Durrent K. R. et al.: "A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer". J. Clin. Oneal., 1986, 4, 1326.
[5] Early Breast Cancer Trialists'Collaborative Group: "Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women". Lancet, 1992, 339 (1), 71.
[6] Spinelli G., Bardozzi N., Citemessi A., Fontonarosa M., Curiel P.: "Endometrial carcinoma in tamoxifen treated cancer patients". J. Chemother., 1991, 3, 267.
[7] Nuovo M.A., Nuovo G. Y., McCaffrey R. M., Levi R. U., Barron B., Winkler B.: "Endometrial polyps in postmenopausal patients receiving tamoxifen". Jnt. J. Gynecol. Pathol., 1983, 8, 125.
[8] Cross S. S., Ismail S.: "Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy. Case report". Br. J. Obstet. Gynecol., 1990, 97, 551.
[9] Corly D., Rowe J., Curtis M. T., Hogon W. N., Noumoff J. S., Livolsi W. A.: "Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy". Obstet. Gynecol., 1992, 79, 111.
[10] Gusberg S. B.: "Tamoxifen for breast cancer: associated endometrial cancer". Cancer, 1990, 65, 1463.
[11] Clark J. H., Anderson J. N., Peck S.: "Estrogen receptor-antiestrogen complex: Atypical binding by uterine nuclei and effects on uterine growth". Steroids, 1973, 22, 707.
[12] Ferrazi E., Cartei G., Mattarazoa R., Fiorentino M.: "Oestrogenlike effect of tamoxifen on vagin*l epithelium". Br. Med. J., 1977, 1, 1351.
[13] Boccardo F., Bruzzi P., Rubagotti A., Nocolo G., Rosso R.: "Estrogen- like action of tamoxifen vagin*l epithelium in breast cancer patients". Oncology, 1981, 38, 281.
[14] Boccardo F., Guarnieri D., Rubagotti A., Casterelli G. L., Bentiroglio G. et al.: "Endocrine effects of tamoxifen in postmenopausal breast cancer patients". Tumor, 1984, 70, 61.
[15] Rayter Z., Gazet J. C., Shepherd J., Trott P.A., Fisher C., Svenson W. E., Ford H. T., Hern R. A.: " Gynecological cytology and pelvicultrasonography in patients with breast cancer taking tamoxifen compared with controls". Eur. J. Surg. Oneal., 1994, 20, 134.
[16] Manni A., Pearson 0. H.: "Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: Effects on ovarian function". Cancer Treat. Rep., 1980, 64, 779.
[17] Rose D. P., Davis T. E.: "Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients". Cancer Res., 1980, 40, 4043.
[18] Sherman B. M., Chapler F. K., Crickard K., Wycoff D.: "Endocnne consequences of continuous antestrogen therapy with tamoxifen in premenopausal women". J. Clin. Invest., 1979, 64, 398.
[19] Lahti E., Blanco G., Kauppila A., Sarkkinen M.A., Taskinen P., Laatikainen T.: "Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen". Obstet. Gynecol., 1993, 81, 660.
[20] Breast Cancer Trials Committee, Scottish Cancer Trials Office(MRC), Edinburgh: "Adjuvant tamoxifen in the management of operable breast cancer: The Scottish Trial". Lancet, 1987, ii, 171.
[21] Malfetano J. H.: "Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients". Gynecol. Oncol., 1990, 39, 82.
[22] Fornander T., Cedermark B., Mattsson A. et al.: "Adjuvant tamoxifen in the management in early breast cancer: Occurrence of new primary cancer". Lancet, 1989, i, 117.
[23] Anderson M., Storm H. H., Mouridsen H. T.: "Incidence of new primary cancers after adjuvant therapy and radiotherapy for early breast cancer". J. Natl. Cancer Inst., 1991, 83, 1013.
[24] Ozsener S., Ozaran A., ltil I., Dikmen Y.: "Endometrial pathology of 104 postmenopausal breast cancer patients treated with tamoxifen". Eur. J. Gynaecol. Oncol., 1998, 19 (6), 580.
[25] Treilleux T., Mignotte H., Clement-Chassagne C., Guastalla P., Bailly C.: "Tamoxifen and malignant epithelial-nonepithelial tumours of the endometrium: report of six cases and review of the literature". Eur. J. Surg. Oncol., 1999, 25 (5), 477.
[26] Bernstein L., Deapen D., Cerhan J. R., Schwartz S. M., Liff L., McGann-Maloney E. et al.: "Tamoxifen therapy for breast cancer and endometrial cancer risk". J. Natl. Cancer Inst., 1999, 6, 91(19), 1654.
[27] Love C. D., Muir B. B., Scrimgeour J.B., Leonard R. C., Dillon P., Dixon J. M.: "Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening". J. Clin. Oncol., 1999, 17 (7), 2050.
